Global Trust Asset Management LLC bought a new stake in UnitedHealth Group Inc (NYSE:UNH) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 2,814 shares of the healthcare conglomerate’s stock, valued at approximately $620,000.
Other hedge funds have also recently made changes to their positions in the company. Exane Derivatives raised its stake in UnitedHealth Group by 15,333.3% in the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after purchasing an additional 460 shares during the last quarter. Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $114,000. Acrospire Investment Management LLC increased its stake in shares of UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after acquiring an additional 400 shares during the last quarter. Jacobi Capital Management LLC increased its stake in shares of UnitedHealth Group by 6.6% during the 2nd quarter. Jacobi Capital Management LLC now owns 729 shares of the healthcare conglomerate’s stock valued at $136,000 after acquiring an additional 45 shares during the last quarter. Finally, Intellectus Partners LLC increased its stake in shares of UnitedHealth Group by 18.2% during the 2nd quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock valued at $152,000 after acquiring an additional 126 shares during the last quarter. 86.83% of the stock is owned by hedge funds and other institutional investors.
A number of research analysts have recently commented on UNH shares. Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, December 27th. Evercore ISI reaffirmed an “outperform” rating and set a $255.00 price objective (up previously from $235.00) on shares of UnitedHealth Group in a research note on Friday, January 12th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective for the company in a research note on Saturday, January 20th. Wells Fargo & Co reaffirmed an “outperform” rating and set a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Finally, ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $245.14.
Shares of UnitedHealth Group Inc (UNH) opened at $226.94 on Wednesday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a fifty-two week low of $162.74 and a fifty-two week high of $250.79. The stock has a market capitalization of $219,600.00, a PE ratio of 23.89, a PEG ratio of 1.31 and a beta of 0.74.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. UnitedHealth Group’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.11 EPS. research analysts expect that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date of this dividend is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 31.58%.
ILLEGAL ACTIVITY NOTICE: “Global Trust Asset Management LLC Invests $620,000 in UnitedHealth Group Inc (UNH) Stock” was published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3261024/global-trust-asset-management-llc-invests-620000-in-unitedhealth-group-inc-unh-stock.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.